Gi Duk Bae

Gi Duk Bae is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of bacteriophage compositions. With a total of 16 patents to his name, Bae's work has the potential to impact the treatment of infectious diseases in animals.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Bacteriophage and composition comprising same." This patent focuses on bacteriophage φCJ(KCCMP) and a composition that utilizes this bacteriophage as an active ingredient. The invention aims to provide a method for preventing and treating infectious diseases caused by enterotoxigenic E. coli (ETEC) in animals, excluding humans. Another notable patent is "Composition comprising CJLP475 strain and CJLP17 strain and use thereof," which relates to a composition that includes the CJLP475 strain and CJLP17 strain, both of which have been deposited under specific accession numbers.

Career Highlights

Gi Duk Bae is currently associated with CJ Cheiljedang Corporation, a leading company in the food and biotechnology sectors. His work at the company has allowed him to focus on innovative solutions that address critical health issues in livestock.

Collaborations

Bae collaborates with talented individuals such as Jae Won Kim and Eun Mi Shin, who contribute to his research and development efforts. Their combined expertise enhances the potential for groundbreaking discoveries in their field.

Conclusion

Gi Duk Bae's innovative work in bacteriophage research exemplifies the importance of biotechnology in addressing health challenges. His contributions are paving the way for new treatments that could significantly benefit animal health and welfare.

This text is generated by artificial intelligence and may not be accurate.